These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Influence of gadolinium chelates on phosphorus-31 magnetic resonance spectroscopy of the liver. Bauer H; Negishi C; Weinmann HJ Invest Radiol; 1994 Aug; 29(8):752-7. PubMed ID: 7960625 [TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA. Saito S; Obata A; Kashiwagi Y; Abe K; Murase K Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774 [TBL] [Abstract][Full Text] [Related]
5. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739 [TBL] [Abstract][Full Text] [Related]
6. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. Narita M; Hatano E; Arizono S; Miyagawa-Hayashino A; Isoda H; Kitamura K; Taura K; Yasuchika K; Nitta T; Ikai I; Uemoto S J Gastroenterol; 2009; 44(7):793-8. PubMed ID: 19404564 [TBL] [Abstract][Full Text] [Related]
7. Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters. Leonhardt M; Keiser M; Oswald S; Kühn J; Jia J; Grube M; Kroemer HK; Siegmund W; Weitschies W Drug Metab Dispos; 2010 Jul; 38(7):1024-8. PubMed ID: 20406852 [TBL] [Abstract][Full Text] [Related]
8. Gadolinium-ethoxybenzyl-DTPA, a new liver-directed magnetic resonance contrast agent. Absence of acute hepatotoxic, cardiovascular, or immunogenic effects. Mühler A; Clément O; Saeed M; Lake JR; Stites DP; Berthezène Y; Brasch RC Invest Radiol; 1993 Jan; 28(1):26-32. PubMed ID: 8425849 [TBL] [Abstract][Full Text] [Related]
9. Measuring hepatic functional reserve using T1 mapping of Gd-EOB-DTPA enhanced 3T MR imaging: A preliminary study comparing with Nakagawa M; Namimoto T; Shimizu K; Morita K; Sakamoto F; Oda S; Nakaura T; Utsunomiya D; Shiraishi S; Yamashita Y Eur J Radiol; 2017 Jul; 92():116-123. PubMed ID: 28624009 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid. Jia J; Puls D; Oswald S; Jedlitschky G; Kühn JP; Weitschies W; Hosten N; Siegmund W; Keiser M Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116 [TBL] [Abstract][Full Text] [Related]
11. Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats. Schmitz SA; Mühler A; Wagner S; Wolf KJ Invest Radiol; 1996 Mar; 31(3):154-60. PubMed ID: 8675423 [TBL] [Abstract][Full Text] [Related]
12. Stereospecific binding of MRI contrast agents to human serum albumin: the case of Gd-(S)-EOB-DTPA (Eovist) and its (R) isomer. Vander Elst L; Chapelle F; Laurent S; Muller RN J Biol Inorg Chem; 2001 Feb; 6(2):196-200. PubMed ID: 11293414 [TBL] [Abstract][Full Text] [Related]
13. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MR finding of radiation-induced hepatic injury: relationship to absorbed dose and time course after irradiation. Okamoto D; Nishie A; Asayama Y; Tajima T; Ishigami K; Kakihara D; Nakayama T; Ohga S; Yoshitake T; Shioyama Y; Honda H Magn Reson Imaging; 2014 Jul; 32(6):660-4. PubMed ID: 24666574 [TBL] [Abstract][Full Text] [Related]
14. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat. Shuter B; Tofts PS; Wang SC; Pope JM Magn Reson Imaging; 1996; 14(3):243-53. PubMed ID: 8725190 [TBL] [Abstract][Full Text] [Related]
15. Enhancements in hepatobiliary imaging: the spectrum of gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid usages in hepatobiliary magnetic resonance imaging. Channual S; Pahwa A; Lu DS; Raman SS Abdom Radiol (NY); 2016 Sep; 41(9):1825-41. PubMed ID: 27225503 [TBL] [Abstract][Full Text] [Related]
16. Phantom and animal studies of a new hepatobiliary agent for MR imaging: comparison of Gd-DTPA-DeA with Gd-EOB-DTPA. Yoshikawa K; Inoue Y; Akahane M; Shimada M; Itoh S; Seno A; Hayashi S J Magn Reson Imaging; 2003 Aug; 18(2):204-9. PubMed ID: 12884333 [TBL] [Abstract][Full Text] [Related]
17. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation. Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073 [TBL] [Abstract][Full Text] [Related]
18. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid. Lin CY; Chang WC; Chou CT; Chen RC J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453 [TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases. Mühler A; Clément O; Vexler V; Berthezène Y; Rosenau W; Brasch RC Radiology; 1992 Jul; 184(1):207-13. PubMed ID: 1609081 [TBL] [Abstract][Full Text] [Related]
20. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs. Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H; Weinmann HJ Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]